Sharp Edge Labs
Advancing cellular biology research with innovative biosensor technology for precise, high-throughput screening since 2011. Based in Pittsburgh, Pennsylvania.
Advancing cellular biology research with innovative biosensor technology for precise, high-throughput screening since 2011. Based in Pittsburgh, Pennsylvania.
Sharp Edge Labs is a biotechnology startup that has been advancing cellular biology research since 2011. Based in Pittsburgh, Pennsylvania, the company specializes in innovative biosensor technology for precise, high-throughput screening. Utilizing fluorogenic activating proteins, Sharp Edge Labs offers a range of specialized biosensors designed for the cellular biology research sector. These biosensors provide a method for detecting cellular changes suitable for high-throughput screening and subsequent analysis. Founded in 2011, Sharp Edge Labs has garnered attention within the industries of biotechnology, life sciences, and medical devices. Notably, the company received a $3.55M Venture Round investment on 08 August 2019. Despite the absence of disclosed investors, this investment underscores the market's confidence in the potential of Sharp Edge Labs and their innovative biosensor technology.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $3.55M | - | 08 Aug 2019 | |
| Series C | Unknown | 1 |
|
30 Jun 2017 |
| Convertible Note | Unknown | 1 |
|
03 Sep 2016 |
| Series B | $600.00K | 2 |
|
19 Aug 2014 |
| Venture Round | $100.00K | - | 10 Jan 2014 |
No recent news or press coverage available for Sharp Edge Labs.
We care about your data, and we'd love to use cookies make your experience better.
